Results 21 to 30 of about 13,204 (176)

Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature

Pathophysiology, 2023
The prevalence of opioid use among pregnant people has been increasing over the past few decades, with a parallel increase in the rate of neonatal abstinence syndrome.
Alice Ordean, Meara Tubman-Broeren
doaj   +1 more source

Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant. [PDF]

, 2016
Opioid use in pregnancy has increased dramatically over the past decade. Since prenatal opioid use is associated with numerous obstetrical and neonatal complications, this now has become a major public health problem.
Davis, Jonathan M., Kraft, Walter K., Stover, Megan W.   +2 more
core   +2 more sources

The systems medicine of neonatal abstinence syndrome

Frontiers in Bioscience-Landmark, 2020
This review will focus on a systems medicine approach to neonatal abstinence syndrome (NAS). Systems medicine utilizes information gained from the application of “omics” technology and bioinformatics (1).
William L. Stone, David L. Wood, Nathaniel A. Justice, Darshan S. Shah, Martin E.Olsen, Des Bharti   +5 more
doaj   +1 more source

Neonatal Abstinence Syndrome

Pediatrics, 2014
Neonatal abstinence syndrome (NAS) is a result of the sudden discontinuation of fetal exposure to substances that were used or abused by the mother during pregnancy. Withdrawal from licit or illicit substances is becoming more common among neonates in both developed and developing countries.
Marela Šain Tuka, Vesna Herceg
openaire   +3 more sources

Opioid Use in Pregnant Women and Neonatal Abstinence Syndrome—A Review of the Literature

Toxics, 2019
Opiate use during pregnancy has been an increasing problem over the last two decades, making it an important social and health concern. The use of such substances may have serious negative outcomes in the newborn, and clinical and cognitive conditions ...
Fábio Martins, David Oppolzer, Catarina Santos, Mário Barroso, Eugenia Gallardo   +4 more
doaj   +1 more source

Problematisation and regulation: bodies, risk, and recovery within the context of Neonatal Abstinence Syndrome [PDF]

, 2018
Background Neonatal Abstinence Syndrome (NAS) is an anticipated effect of maternal drug use during pregnancy. Yet it remains a contested area of policy and practice.
Chandler, Amy, Cooper, Sarah, Cunningham-Burley, Sarah, Elliott, Lawrie, Midgley, Paula, Whittaker, Anne   +5 more
core   +3 more sources

Commentary on Gibson et al. (2017): Gestational age and the severity of neonatal abstinence syndrome [PDF]

, 2017
No abstract ...
Allocco, Bier, Desai, Dryden, Gibson, Hodgson, Jones, Kocherlakota, Liu, Mactier, Maeda, McGlone, McGlone, Noormohammadi, Steinhorn, Yuan   +15 more
core   +1 more source

Project Console: a quality improvement initiative for neonatal abstinence syndrome in a children’s hospital level IV neonatal intensive care unit

BMJ Open Quality, 2021
Objective To improve care for infants with neonatal abstinence syndrome.Design Infants with a gestational age of ≥35 weeks with prenatal opioid exposure were eligible for our quality improvement initiative.
Kathryn L Ponder, Charles Egesdal, Joanne Kuller, Priscilla Joe   +3 more
doaj   +1 more source

Neonatal Abstinence Syndrome: Twins Case Series

Frontiers in Pediatrics, 2017
BackgroundUse or abuse of opioids and related drugs during pregnancy increases the risk of maternal and neonatal morbidities, including increased susceptibility to Neonatal Abstinence Syndrome (NAS).
Rajesh Pandey, Narmada Pandey Sapkota, Deepak Kumar   +2 more
doaj   +1 more source

Neonatal Abstinence Syndrome

Anbalagan S, Falkowitz DM, Mendez MD.
europepmc   +2 more sources